EPT Disclosure
14 June 2006 - 9:15PM
UK Regulatory
RNS Number:5572E
Deutsche Bank AG London
14 June 2006
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader Deutsche Bank AG London
Company dealt in Cambridge Antibody Technology Group Plc
Class of relevant security to which the Ordinary
dealings being disclosed relate (Note 1)
Date of dealing 13/06/2006
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3)
25,200 #13.075 #13.07
Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3)
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
e.g. CFD
CFD Long 25,000 #13.07
CFD Long 200 #13.075
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money
purchasing, to which the option American, Date paid/received per
e.g. call option varying etc. relates (Note 5) price European etc. unit (Note 3)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.
NONE
Date of disclosure 14/06/2006
Contact name Kelly-Jade Ledwich
Telephone number 020 7545 7804
Name of offeree/offeror with which connected AstraZeneca Plc
Nature of connection (Note 6) Adviser to the offeror
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSFEFFLSMSEFM
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024